What if you'd held DMAC?
A $1,000 investment in DiaMedica Therapeutics Inc. (DMAC) at the month-end close of 2012-08 would be worth $190 at the close of 2026-08 — -81.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $5,480.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2012
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2012 | $1,000 | — |
| 2013 | $665 | -33.5% |
| 2014 | $43.22 | -93.5% |
| 2015 | $82.11 | +90.0% |
| 2016 | $94.90 | +15.6% |
| 2017 | $216 | +127.7% |
| 2018 | $126 | -41.8% |
| 2019 | $210 | +66.7% |
| 2020 | $438 | +109.1% |
| 2021 | $161 | -63.2% |
| 2022 | $68.28 | -57.6% |
| 2023 | $123 | +79.7% |
| 2024 | $235 | +91.2% |
| 2025 | $344 | +46.6% |
| 2026 | $294 | -14.4% |
Best and worst month-end to buy
The best single month-end close to have bought DMAC was 2015-01 ($0.98): $1,000 then is $6,949 today. The worst was 2012-09 ($37.98): $1,000 then is $179.
FAQ
What would $1,000 in DMAC be worth today?
A $1,000 investment in DiaMedica Therapeutics Inc. (DMAC) at the start of 2012 would be worth about $190 today, a total return of -81.0%. Dividends are reinvested in these figures.
What were the best and worst years for DMAC?
DiaMedica Therapeutics Inc. (DMAC)'s strongest calendar year since 2012 was 2017, a +127.7% return — $1,000 held through that year became about $2,277 by year-end. Its weakest year was 2014, at -93.5%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in DMAC have grown?
Investing $100 at the end of every month since 2012-08 would have grown to about $32,727 on $16,900 invested.
Did DMAC beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $5,480. DMAC trailed the S&P 500 by +96.5% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
DiaMedica Therapeutics Inc. (DMAC) historical total-return data from 2012-08 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.